Mehalick David
Insider CIK 1846623 · COEP CEO and President, Director, 10% owner · COEP CEO and President, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| COEP Coeptis Therapeutics Holdi | A Award | 2026-02-11 | 2026-02-13 | 51,250 | — | $0 | 330,192 | SEC↗ |
| COEP Coeptis Therapeutics Holdi | M Exercise | 2026-02-11 | 2026-02-13 | 148,875 | $7.05 | $1.05M | 330,192 | SEC↗ |
| COEP Coeptis Therapeutics Holdi | A Award deriv | 2025-03-04 | 2025-03-06 | 28,875 | — | $0 | 200,125 | SEC↗ |
| COEP Coeptis Therapeutics Holdi | P Buy | 2024-01-08 | 2024-01-09 | 6,000 | $0.67 | $4.0K | 2,768,611 | SEC↗ |
| COEP Coeptis Therapeutics Holdi | P Buy | 2024-01-08 | 2024-01-09 | 14,004 | $0.66 | $9.2K | 2,782,615 | SEC↗ |
| COEP Coeptis Therapeutics Holdi | P Buy | 2024-01-05 | 2024-01-09 | 5,050 | $0.69 | $3.5K | 2,762,611 | SEC↗ |
| COEP Coeptis Therapeutics Holdi | G Gift | 2023-12-07 | 2023-12-11 | 700,000 | — | $0 | 2,757,561 | SEC↗ |
| COEP Coeptis Therapeutics Holdi | A Award deriv | 2023-01-27 | 2023-01-31 | 250,000 | — | $0 | 250,000 | SEC↗ |
| COEP Coeptis Therapeutics Holdi | A Award deriv | 2023-01-27 | 2023-01-31 | 375,000 | — | $0 | 375,000 | SEC↗ |
| COEP Coeptis Therapeutics Inc. | S Sale | 2021-11-16 | 2021-11-18 | 1,200,000 | — | $0 | 1,800,000 | SEC↗ |